147 related articles for article (PubMed ID: 8394364)
1. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
Thulasi R; Harbour DV; Thompson EB
J Biol Chem; 1993 Aug; 268(24):18306-12. PubMed ID: 8394364
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.
Zhou F; Medh RD; Thompson EB
J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
Yuh YS; Thompson EB
J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells.
Thompson EB; Thulasi R; Saeed MF; Johnson BH
Ann N Y Acad Sci; 1995 Jun; 761():261-75. PubMed ID: 7625725
[TBL] [Abstract][Full Text] [Related]
6. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.
Ma T; Mahajan PB; Thompson EA
Mol Endocrinol; 1992 Jun; 6(6):960-8. PubMed ID: 1495494
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
Maroder M; Martinotti S; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
Nucleic Acids Res; 1990 Mar; 18(5):1153-7. PubMed ID: 2320412
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide of c-myc discriminates between zinc- and dexamethasone-induced synthesis of metallothionein.
Takeda A; Norris JS; Iversen PL; Ebadi M
Pharmacology; 1994 Feb; 48(2):119-26. PubMed ID: 8134403
[TBL] [Abstract][Full Text] [Related]
11. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
Ashraf J; Kunapuli S; Chilton D; Thompson EB
J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
[TBL] [Abstract][Full Text] [Related]
12. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
[TBL] [Abstract][Full Text] [Related]
13. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
14. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.
Rhee K; Bresnahan W; Hirai A; Hirai M; Thompson EA
Cancer Res; 1995 Sep; 55(18):4188-95. PubMed ID: 7664296
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
Fujimoto K; Takahashi M
Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc.
Ayala-Torres S; Zhou F; Thompson EB
Exp Cell Res; 1999 Jan; 246(1):193-202. PubMed ID: 9882528
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.
Kaptein JS; Lin CK; Wang CL; Nguyen TT; Kalunta CI; Park E; Chen FS; Lad PM
J Biol Chem; 1996 Aug; 271(31):18875-84. PubMed ID: 8702548
[TBL] [Abstract][Full Text] [Related]
18. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.
Zhou F; Thompson EB
Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
Goya L; Maiyar AC; Ge Y; Firestone GL
Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]